Opyl Limited Stock Australian S.E.
Equities
OPL
AU0000062838
Advanced Medical Equipment & Technology
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
- AUD | -.--% |
|
-.--% | -.--% |
Jun. 06 | Opyl Secures First TrialGen Contract with Brain Vector | MT |
Apr. 29 | Opyl Expands TrialKey Coverage; Shares Up 38% | MT |
Sales 2022 | 902K 606K | Sales 2023 | 618K 415K | Capitalization | 1.76M 1.18M |
---|---|---|---|---|---|
Net income 2022 | -2M -1.34M | Net income 2023 | -1M -672K | EV / Sales 2022 | 1.96 x |
Net cash position 2022 | 786K 528K | Net cash position 2023 | 153K 103K | EV / Sales 2023 | 2.6 x |
P/E ratio 2022 |
-1.23
x | P/E ratio 2023 |
-1.02
x | Employees | - |
Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 64.77% |
Managers | Title | Age | Since |
---|---|---|---|
Saurabh Jain
CEO | Chief Executive Officer | - | Nov. 23 |
Marc Angelone
FOU | Founder | - | 94-01-16 |
Damon Rasheed
CTO | Chief Tech/Sci/R&D Officer | - | 19-01-29 |
Members of the board | Title | Age | Since |
---|---|---|---|
Mark Simari
BRD | Director/Board Member | 54 | 23-09-03 |
Antanas Guoga
BRD | Director/Board Member | 50 | 23-09-03 |
Marc Angelone
FOU | Founder | - | 94-01-16 |
1st Jan change | Capi. | |
---|---|---|
+42.32% | 9.46B | |
+33.70% | 4.36B | |
-40.36% | 2.21B | |
-9.44% | 1.63B | |
-29.34% | 1.2B | |
-42.86% | 974M | |
-11.20% | 936M | |
-46.87% | 739M | |
-31.84% | 581M |
- Stock Market
- Equities
- OPL Stock
- OPL Stock